Specifically, the anti-aging SIRT1, that is reduced in lungs of COPD patients, seems to protect against emphysema through FOXO3 (Forkhead box O3)-mediated reduction of cellular senescence, independently of inflammation [53]. This evidence concerns the gene FOXO3 and pulmonary emphysema.